+349.5%
AXON vs BBIO
+154.9%
+194.7%
-65.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +1.6% | -0.9% | +0.5% |
| 7D | -4.7% | -1.9% | -2.7% | -4.4% |
| 30D | -21.5% | +14.8% | -36.3% | -23.1% |
| 3M | -51.5% | -6.0% | -45.5% | -51.1% |
| 6M | -24.7% | +19.4% | -44.1% | -26.8% |
| YTD | -47.1% | +2.0% | -49.0% | -47.7% |
| 1Y | -43.7% | +18.9% | -62.6% | -45.6% |
| 3Y | +34.5% | +166.7% | -132.2% | +11.5% |
| 5Y | +72.4% | +73.8% | -1.4% | +19.2% |
| All | +349.5% | +154.9% | +194.7% | +136.0% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling